USPH.NYSEU S Physical Therapy INC /NV

Form 4: USPH COO Sells Shares, Discloses Vesting Schedule

Sentiment:

Insider Transaction Report

📋All filings for U S Physical Therapy INC /NV
🔒Login to Follow

U.S. Physical Therapy COO Graham D. Reeve sold 743 shares of common stock at a weighted average price of $71.01 per share.

Summary

  • Graham D. Reeve, Chief Operating Officer (COO) of U.S. Physical Therapy, Inc. (USPH), reported a sale of common stock.
  • The transaction involved 743 shares disposed of on November 24, 2025.
  • The shares were sold at a weighted average price of $71.01, with individual transaction prices ranging from $71.01 to $71.31 per share.
  • Following this transaction, Mr. Reeve directly beneficially owns 20,740 shares of common stock.
  • An additional 1,808 shares are indirectly beneficially owned through the Reeve Trust.
  • The direct beneficial ownership includes 13,348 shares of restricted stock granted under the Company's Amended and Restated 2003 Stock Incentive Plan.
  • These restricted shares are subject to a vesting schedule, with tranches lapsing between March 6, 2026, and March 6, 2029, contingent on Mr. Reeve's continued employment.

Sentiment

Score: 5

Explanation: The filing is a factual report of an insider stock transaction and does not inherently convey positive or negative sentiment regarding the company's performance or prospects. The sale amount is relatively small compared to total holdings.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction report provides specific details about a stock sale by a key executive at U.S. Physical Therapy, Inc. It does not offer broader insights into industry trends or competitive landscape.

Related Party Transactions

  • Graham D. Reeve indirectly beneficially owns 1,808 shares through the Reeve Trust.

Stakeholder Impact

  • Shareholders may monitor insider transactions as a signal of management's confidence, though the reported sale is a relatively small portion of the COO's total beneficial ownership.

Next Steps

  • Vesting of remaining restricted shares will occur on various dates between March 6, 2026, and March 6, 2029, contingent on continued employment.

Key Dates

DateDescription
11/24/2025Transaction Date: Sale of 743 shares of Common Stock by Graham D. Reeve.
11/25/2025Signature Date of the Form 4 filing.
03/06/2026Vesting of 1,964 restricted shares.
05/20/2026Vesting of 1,324 restricted shares.
08/20/2026Vesting of 1,324 restricted shares.
11/20/2026Vesting of 1,324 restricted shares.
03/06/2027Vesting of 1,332 restricted shares.
05/20/2027Vesting of 1,012 restricted shares.
08/20/2027Vesting of 1,012 restricted shares.
11/20/2027Vesting of 1,012 restricted shares.
03/06/2028Vesting of 1,016 restricted shares.
05/20/2028Vesting of 506 restricted shares.
08/20/2028Vesting of 506 restricted shares.
11/20/2028Vesting of 506 restricted shares.
03/06/2029Vesting of 510 restricted shares.

Keywords

USPH, U.S. Physical Therapy, Graham D. Reeve, COO, Insider Transaction, Form 4, Stock Sale, Beneficial Ownership, Restricted Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.